G93.42

Clinical Causes: MLC is primarily caused by genetic mutations that affect the development and maintenance of brain white matter. It is inherited in an autosomal recessive pattern, meaning an individual needs to inherit two copies of the faulty gene—one from each parent—to develop the disorder. The most common gene mutations implicated include those in the MLC1 gene and, less frequently, the HEPACAM gene. These genetic alterations disrupt normal brain tissue development, leading to abnormal white matter formation and cyst development.

Key Symptoms: The symptoms of megalencephalic leukoencephalopathy with subcortical cysts can vary widely among individuals, but common features include: - Enlarged head size (macrocephaly) noticeable within the first year of life - Mild to moderate muscle weakness (hypotonia) - Lack of coordination and balance issues - Delayed motor development milestones - Speech delays or difficulties - Seizures in some cases - Gradual regression of previously attained skills - Cognitive impairment, which may range from mild to moderate The progression of symptoms can be slow, with some individuals maintaining independence well into adolescence or adulthood, while others might experience more significant disability.

Diagnosis Path: Diagnosing MLC involves a combination of clinical assessment and specialized testing: - Medical history and physical examination focusing on head size and neurological function - Brain imaging studies, especially magnetic resonance imaging (MRI), revealing characteristic features such as enlarged brain white matter and subcortical cysts - Genetic testing to identify mutations in the MLC1 or HEPACAM genes, confirming the diagnosis - Electromyography (EMG) and nerve conduction studies may be used to assess nerve and muscle function - Neuropsychological assessments to evaluate cognitive development and any delays Early diagnosis is crucial for managing symptoms and providing appropriate support and therapies.

Treatment Protocols: Currently, there is no cure for megalencephalic leukoencephalopathy with subcortical cysts. Treatment focuses on managing symptoms and improving quality of life: - Physical therapy to enhance motor skills and coordination - Speech and language therapy to support communication delays - Occupational therapy to assist with daily living activities - Seizure management with appropriate medications if seizures occur - Regular developmental assessments to monitor progress - Supportive educational services tailored to individual needs Research continues to explore potential therapies that address the underlying genetic causes, but management remains symptomatic and supportive. Overall, multidisciplinary care involving neurologists, geneticists, therapists, and educators can help individuals with MLC lead active lives as much as possible.